Mrs Heidi Lyn Mclennan, OT/L | |
1 Verney Drive, Greenfield, NH 03047 | |
(603) 547-3311 | |
(603) 547-6212 |
Full Name | Mrs Heidi Lyn Mclennan |
---|---|
Gender | Female |
Speciality | Occupational Therapist |
Location | 1 Verney Drive, Greenfield, New Hampshire |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1821397134 | NPI | - | NPPES |
496604 | Other | MEDICARE | |
4978803 | Medicaid | VA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
225X00000X | Occupational Therapist | 0119003385 (Virginia) | Secondary |
225X00000X | Occupational Therapist | NHLICENSENO2260 (New Hampshire) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mrs Heidi Lyn Mclennan, OT/L 1 Verney Drive, Greenfield, NH 03047 Ph: (603) 547-3311 | Mrs Heidi Lyn Mclennan, OT/L 1 Verney Drive, Greenfield, NH 03047 Ph: (603) 547-3311 |
News Archive
St. Jude Children's Research Hospital scientists have used sophisticated pharmacologic modeling and simulation to translate preclinical findings into a successful phase I clinical trial of a chemotherapy agent for treatment of ependymoma. The research marked the first time the approach has been used to calculate drug doses for a clinical trial in pediatric brain tumor patients.
A panel of prominent medical school deans from across the country convened yesterday in New York City to discuss the future of annual medical school rankings issued by U.S. News & World Report, which are now celebrating their 20th anniversary.
GfK Asia releases its Pan Asia optical retailers and consumers preference survey information in line with the 17th Hong Kong Optical Fair, hosted by Hong Kong Trade Development Council. The five key regions surveyed in October 2009 include China, Hong Kong, Korea, Singapore and Malaysia. The survey shows that 70% of optical retailers indicate business will be better or the same in 2010.
US-Australian drug discovery company, Novogen Limited announced today that its candidate cytotoxic chemotherapy drug, Anisina, has proved an effective anti-cancer agent in animals, the result of which it now has been fast-tracked by the Company to come into the clinic.
A new physical form of proteins developed by researchers at The University of Texas at Austin could drastically improve treatments for cancer and other diseases, as well as overcome some of the largest challenges in therapeutics: delivering drugs to patients safely, easily and more effectively.
› Verified 8 days ago
Mrs. Tara Anne Stetson, MSOT, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1 Verney Dr, Greenfield, NH 03047 Phone: 603-547-3311 | |
Lauren A Smith, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1 Verney Dr, Greenfield, NH 03047 Phone: 603-547-3311 Fax: 603-547-3232 | |
Ms. Alisha Nicole Dimasi, MS, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1 Verney Dr, Greenfield, NH 03047 Phone: 603-547-3311 Fax: 603-547-3232 | |
Jennifer Booth, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1 Verney Dr, Greenfield, NH 03047 Phone: 603-547-3311 Fax: 603-547-3571 | |
Linda E Murphy, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1 Verney Dr, Greenfield, NH 03047 Phone: 603-547-3311 Fax: 603-547-3232 | |
Amy Marie Nilges, MS, OTR/L Occupational Therapist Medicare: Medicare Enrolled Practice Location: 1 Verney Dr, Greenfield, NH 03047 Phone: 603-547-3311 Fax: 603-547-3232 | |
Jacquelyn A Dempsey, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1 Verney Dr, Greenfield, NH 03047 Phone: 603-547-3311 Fax: 603-547-3232 |